At ESMO 2025, the conversation around artificial intelligence in oncology was impossible to ignore. From accelerating drug development to enabling remote patient monitoring, AI is completely changing cancer care— and EVERSANA has consistently leveraged these innovations to deliver smarter, faster solutions for clients.
In a recent interview with pharmaphorum, Barry Vucsko, Senior Vice President, Strategic Development, EVERSANA INTOUCH, shared his perspective on why AI matters more to oncology than any other therapeutic area and what’s next for this fast-moving space.
Why AI Is Critical for Oncology
“Oncology moves fast—and so does AI,” Barry explains. The pace of innovation in cancer care demands tools that can keep up. EVERSANA’s long-standing experience with AI, combined with our new AI Agency platform, is helping teams deliver compliant, omnichannel content at unprecedented speed.
New Guidance for AI in Practice
ESMO recently published its first guidance on the safe use of large language models in oncology practice. Known as ELCAP, this framework aims to help patients, clinicians, and institutions adopt AI responsibly. The guidance coincided with a session on ChatGPT and cancer care, underscoring the growing role of AI in clinical workflows.
Opportunities and Obstacles
Barry sees clear opportunities:
- Drug development acceleration
- More efficient clinical trials
- AI-driven imaging and radiology
But challenges remain. Gender and language equity, access in lower-income countries, and the fact that only 5% of pathology labs in Europe are digitized are major hurdles. Without digitization, AI can’t analyze data— making the transition to fully digital labs the critical first step toward progress.
Looking Ahead
Barry predicts that in two years, AI won’t be a headline topic—it will be ubiquitous, seamlessly integrated into every aspect of oncology care.
Want to get ahead of the AI-in-oncology curve?
Learn more about EVERSANA ONCOLOGY®
Author
Barry Vucsko has more than 25 years of marketing, advertising, and consulting experience spanning more than 100 brands and several continents...